Concepedia

Susmith Mukund

SM

Statistics

Publications

17

Citations

2.1K

H-Index

17

Active since

2002

Affiliations

Gilead Sciences (United States)(Current)

Amgen (United States)

Université Bourgogne Franche-Comté

Gene Therapy Laboratory

Genentech

Susmith Mukund is an author at Gilead Sciences (United States) specializing in life sciences, biochemistry, and pharmacology.

Publications per year

2002–2025

17

Publications

17

Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability

Benjamin Lauffer, Robert Mintzer, Rina Fong et al. · Journal of Biological Chemistry · 2013 · 412 citations · Full text

, , +15

Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist

Shivani Ahuja, Susmith Mukund, Lunbin Deng et al. · Science · 2015 · 327 citations · Full text

, , +17

Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation

Ingrid E. Wertz, Kim Newton, Dhaya Seshasayee et al. · Nature · 2015 · 256 citations

, , +12

Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design

E.B. Lansdon, Katherine M. Brendza, Magdeleine Hung et al. · Journal of Medicinal Chemistry · 2010 · 226 citations

, , +17

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 164 citations · Full text

, , +17

1–5 of 17